Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group (Q33885648)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group |
scientific article |
Statements
1 reference
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group (English)
1 reference
E W St Clair
1 reference
R Maini
1 reference
F Breedveld
1 reference
D Furst
1 reference
J Kalden
1 reference
M Weisman
1 reference
J Smolen
1 reference
G Harriman
1 reference
M Feldmann
1 reference
P Lipsky
1 reference
1 December 1999
1 reference
Identifiers
1 reference